Cover Image

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review

Aim. To analyze the efficacy, safety and pharmacoeconomic indicators of ocrelizumab in adult patients with primary progressive multiple sclerosis (PPMS). Methods. An information search was conducted in the databases Embase, PubMed, Cochrane and eLibrary.ru. The levels of evidence were determined in...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. L. Klabukova (Author), M. E. Holownia-Voloskova (Author), M. V. Davydovskaya (Author), T. N. Ermolaeva (Author), E. M. Olyushina (Author), K. I. Polyakova (Author), A. G. Fisun (Author), M. G. Grinin (Author), K. A. Kokushkin (Author)
Format:	Book
Published:	Izdatelstvo OKI, 2018-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ocrelizumab - a monoclonal antibody - in the treatment of adult patients with multiple sclerosis: a systematic review
by: D. L. Klabukova, et al.
Published: (2018)

Economic burden of systemic sclerosis: systematic review
by: D. L. Klabukova, et al.
Published: (2020)

Ocrelizumab as a breakthrogh in multiple sclerosis treatment
by: Marcin Zaniuk, et al.
Published: (2021)

The results of ocrelizumab therapy in patients with multiple sclerosis in the Voronezh region
by: Valeriya A. Bykova, et al.
Published: (2023)

Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis
by: Tereza Gabelić, et al.
Published: (2021)

Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia
by: Mansour A. Alharbi, et al.
Published: (2023)

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
by: Annika Klumpp, MD, et al.
Published: (2022)

ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021)

NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy
by: Simone Dal Bello, et al.
Published: (2024)

Anti-CD20 Cell Therapies in Multiple Sclerosis-A Fixed Dosing Schedule for Ocrelizumab is Overkill
by: Jagannadha Avasarala
Published: (2017)

Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study
by: Marcello Moccia, et al.
Published: (2024)

Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region
by: A. D. Ermolaeva, et al.
Published: (2021)

The strategies of drug supply for patients with chronic hepatitis C
by: E. V. Kornilova, et al.
Published: (2017)

Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018)

Individualized prophylactic treatment of patients with hemophilia A to improve effectiveness and optimize product consumption on the example of octocog alpha and rurioctocog alpha pegol. A systematic literature review
by: A. G. Tolkushin, et al.
Published: (2021)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021)

Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region
by: A. D. Ermolaeva, et al.
Published: (2023)

Pre-analytical stability of ocrelizumab in serum after delayed centrifugation of whole blood
by: Jeongsup Shim, et al.
Published: (2024)

Crucial areas of the economic analysis of public cancer care
by: D. A. Andreev, et al.
Published: (2020)

Ocrelizumab‐induced psoriasiform dermatitis: Case reports and review of the literature
by: Natalia Naranjo Guerrero, et al.
Published: (2023)

Towards Treating Multiple Sclerosis Progression
by: Darius Häusler, et al.
Published: (2024)

Photodynamic therapy as an up-to-date medical technology for the treatment of vulgar acne
by: D. A. Andreev, et al.
Published: (2020)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
by: Weipeng Wei, et al.
Published: (2021)

Progress in the Management of Paediatric-Onset Multiple Sclerosis
by: Aphra Luchesa Smith, et al.
Published: (2020)

Factors Affecting Bone Mineral Density in Male Patients with Primary Progressive Multiple Sclerosis
by: Aslı Çalışkan Arıcan, et al.
Published: (2020)

Progressive Cognitive Impairments in Childhood and Juvenile Multiple Sclerosis
by: J Gordon Millichap
Published: (2010)

Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
by: I. I. Snegireva, et al.
Published: (2018)

Possible effects of electroconvulsive therapy on refractory psychosis in primary progressive multiple sclerosis: A case report
by: Zui Narita, et al.
Published: (2018)

The effect of smoking on the symptoms and progression of multiple sclerosis: a review
by: Afsaneh Shirani, et al.
Published: (2010)

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
by: Gajofatto A
Published: (2017)

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
by: Xiaohong Ma, et al.
Published: (2023)

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis
by: Saeideh Salehizadeh, et al.
Published: (2022)

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question
by: Stefania Federica De Mercanti MD, PhD, et al.
Published: (2020)

Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis
by: Kawita M. S. Kanhai, et al.
Published: (2022)

Quality of Life among Multiple Sclerosis Patients
by: Z. Taraghi, et al.
Published: (2007)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013)

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

Synergy between health technology assessments and clinical guidelines for multiple sclerosis
by: Milou A. Hogervorst, et al.
Published: (2023)